| Literature DB >> 31078140 |
Tai-Hsiang Huang1, Yi-Wen Lin1,2, Chun-Ping Huang2, Jing-Ming Chen3, Ching-Liang Hsieh4,5,6,7.
Abstract
BACKGROUND: Vascular dementia is the second dementing illness after Alzheimer's disease and caused by reduced blood flow to the brain, and affects cognitive abilities. Our previous study found that auricular electrical stimulation (ES) improved motor and learning impairment, and this phenomenon related with nicotinic acetylcholine receptor (nAChR) expressed cells. However, the underlying mechanism was not clear. In the present study, we investigated the effects of auricular ES on cortical blood flow (CBF) and acetylcholine (ACh) - nAChRs expressed cells.Entities:
Keywords: Acetylcholine receptor; Auricular electrical stimulation; Bilateral carotid artery occlusion; Cerebral blood flow; Dementia
Mesh:
Substances:
Year: 2019 PMID: 31078140 PMCID: PMC6511660 DOI: 10.1186/s12929-019-0526-9
Source DB: PubMed Journal: J Biomed Sci ISSN: 1021-7770 Impact factor: 8.410
Latency to step out in the rotarod test. The eighteen Wistar rats were randomly divided into three groups, and time of latency to step out was recorded (s) before 2VO surgery (Pre-2VO). At 21 day after surgery, time of latency to step out was recorded among all groups
| Group | Pre-2VO (s) | Post-2VO (s) |
|---|---|---|
| 2VO + 15-Hz ES | 380.1 ± 101.9 | 197.0 ± 56.7*** |
| 2VO + Sham ES | 303.3 ± 43.6 | 147.3 ± 32.5*** |
| Control | 344.2 ± 82.7 | 280.4 ± 63.7 |
Data were represent as mean ± SD (s); n = 6; ***P < 0.001 Pre-2VO vs. Post-2VO
Fig. 1CBF were measured in Pre-ES, ES and Post-ES phase. After rotarod test, a laser Doppler Blood-Flow Monitor probe was put on rats’ middle cerebral artery under anesthetic condition and CBF were recorded within 20 min as showed
CBF was recorded in the Pre-ES, ES and Post-ES phase. CSF was presented as average within 20 min. The deviation of different phase was calculated at EA vs Pre-ES, Post-ES vs ES, and Post-ES vs Pre-ES column
| 2VO + 15-Hz ES | 2VO + Sham ES | Control | |
|---|---|---|---|
| Pre-ES | 124.7 ± 44.5 | 167.1 ± 48.8 | 242.8 ± 107.2 |
| ES | 144.1 ± 47.7 | 148.0 ± 51.0 | 235.1 ± 113.8 |
| Post-ES | 134.5 ± 53.8 | 136.2 ± 45.9 | 218.5 ± 110.2 |
| EA vs Pre-ES | 19.4 ± 8.4# | − 19.1 ± 30.3 | −7.7 ± 27.7 |
| Post-ES vs ES | −9.5 ± 11.4 | −11.8 ± 21.5 | − 16.7 ± 24.8 |
| Post-ES vs Pre-ES | 9.9 ± 17.9 | −30.9 ± 45.4 | − 24.4 ± 49.8 |
Data represent mean ± SD (n = 6). *p < 0.05, 2VO + 15-Hz ES group vs Control group in Pre-ES phase. #P < 0.05, EA vs Pre-ES phase in the 2VO + 15-Hz ES group
Fig. 2The immunohistochemical staining of the nAChR α4 in the hippocampal CA2 output cortex. The nAChR α4 immunoreactive cells were marked by arrowhead a in 400X and the counts of nAChR α4 immunoreactive cells were increased in 2VO + 15-Hz ES group; b nAChR α4 subtype was recognized in the hippocampal CA2 output cortex. (75 X 75 μm, scale bar = 50 μm); c Data represent mean ± SD in the counts of nAChR α4 immunoreactive cells (n = 6); d The levels of nAChR α4 were increased in western blot analysis in 2VO + 15-Hz ES group; e Data represent mean ± SD in the western blot levels of nAChR α4 (n = 3); *P < 0.05
Fig. 3The immunohistochemical staining of nAChR α4 in the habenular nuclei. The nAChR immunoreactive cells were marked by arrowhead a in 400X and the counts of nAChR immunoreactive cells were increased in 2VO + 15-Hz ES group; b nAChR α4 subtype was recognized in the habenular nuclei. (75 X 30 μm, scale bar = 50 μm); c Data represent mean ± SD in the nAChR immunoreactive cells (n = 6); d The levels of nAChR α4 in western blot analysis; e Data represent mean ± SD in the western blot levels of nAChR α4 (n = 3); *P < 0.05
Fig. 4The immunohistochemical staining of the ChAT in the hippocampal CA2 output cortex. The ChAT immunoreactive cells were marked by arrowhead a in 400X and the counts of ChAT immunoreactive cells had no significant difference in each group; b ChAT was recognized in the hippocampal CA2 output cortex. (75 X 75 μm, scale bar = 50 μm); c Data represent mean ± SD in the counts of ChAT immunoreactive cells (n = 6); d The levels of ChAT in western blot analysis; e Data represent mean ± SD in the western blot levels of ChAT (n = 3)
Fig. 5The immunohistochemical staining of ChAT in habenular nuclei. The ChAT immunoreactive cells were marked by arrowhead a in 400X and the counts of ChAT immunoreactive cells had no significant difference in each group; b ChAT was recognized in the habenular nuclei. (75 X 30 μm, scale bar = 50 μm); c Data represent mean ± SD in the ChAT immunoreactive cells (n = 6); d The levels of ChAT in western blot analysis; e Data represent mean ± SD in the western blot levels of ChAT (n = 3)